Tenet Healthcare Corporation
269.08USD
+10.0200 (+3.87%)
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $4.67▲ | $4.1 | 1 | 1 |
| Next quarter | $5.68▲ | $4.76 | 2 | 0 |
| Current year | $21.22▲ | $17.81 | 1 | 1 |
| Next year | $21.08▲ | $17.73 | 4 | 1 |
Beat in 4 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $4.26 | $6.12 | +1.86 (+43.5%) |
| 2026-03-31 | $4.17 | $4.82 | +0.65 (+15.7%) |
| 2025-12-31 | $4.07 | $4.7 | +0.63 (+15.6%) |
| 2025-09-30 | $3.35 | $3.7 | +0.35 (+10.5%) |
366 ratings from 36 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| Wells Fargo | Maintained | Overweight | $231 $281 | Aug 3, 2026 |
| Truist Securities | Maintained | Buy | $270 $290 | Jul 28, 2026 |
| Baird | Maintained | Neutral | $210 $280 | Jul 28, 2026 |
| Guggenheim | Maintained | Buy | $242 $283 | Jul 28, 2026 |
| UBS | Maintained | Buy | $288 $308 | Jul 27, 2026 |
| TD Cowen | Maintained | Buy | $233 $263 | Jul 27, 2026 |
| Morgan Stanley | Maintained | Overweight | $254 $274 | Jul 27, 2026 |
| RBC Capital | Maintained | Outperform | $236 $283 | Jul 27, 2026 |
| Barclays | Maintained | Overweight | $240 $271 | Jul 24, 2026 |
| Guggenheim | Maintained | Buy | $252 $242 | Jul 20, 2026 |
| Wells Fargo | Maintained | Overweight | $213 $231 | Jul 13, 2026 |
| Barclays | Maintained | Overweight | $238 $240 | Jul 9, 2026 |
| TD Cowen | Maintained | Buy | $242 $233 | Jun 22, 2026 |
| Barclays | Maintained | Overweight | $257 $238 | May 5, 2026 |
| Baird | Maintained | Neutral | $245 $210 | May 5, 2026 |
| Stephens & Co. | Maintained | Overweight | $275 $260 | May 4, 2026 |
| RBC Capital | Maintained | Outperform | $277 $236 | May 1, 2026 |
| Guggenheim | Maintained | Buy | $283 $252 | May 1, 2026 |
| Wells Fargo | Maintained | Overweight | $265 $213 | May 1, 2026 |
| Keybanc | Maintained | Overweight | $250 $225 | May 1, 2026 |
| Guggenheim | Maintained | Buy | $271 $283 | Mar 12, 2026 |
| Mizuho | Maintained | Outperform | $235 $265 | Mar 12, 2026 |
| Leerink Partners | Maintained | Outperform | $255 $264 | Feb 20, 2026 |
| Truist Securities | Maintained | Buy | $240 $270 | Feb 17, 2026 |
| Barclays | Maintained | Overweight | $240 $257 | Feb 13, 2026 |
104 filings from 21 insiders · 12 buy / 14 sell over 6m
Officers and directors of THC, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| West NadjaDirector | Sell | 1.2k | $258.80 | $298k | Sep 2, 2026 |
| Foo Lisa YOfficer, EVP, Chief Operating Officer | Sell | 24.0k | $266.32 | $6.39M | Aug 31, 2026 |
| HANEY CECIL DDirector | Gift | 150 | — | — | Aug 28, 2026 |
| SUTARIA SAUMYAChief Executive Officer | Sell | 100.0k | $273.34 | $27.64M | Aug 25, 2026 |
| HANEY CECIL D.Director | Sell | 1.3k | $278.03 | $361k | Aug 24, 2026 |
| ROMO TAMMYDirector | Sell | 7.4k | $260.83 | $1.95M | Aug 7, 2026 |
| BLUNT ROYDirector | Sell | 600 | $262.68 | $158k | Aug 5, 2026 |
| FOO LISA YChief Operating Officer | Sell | 10.0k | $258.03 | $2.58M | Jul 29, 2026 |
| LYNCH CHRISTOPHER SDirector | Sell | 3.8k | $243.44 | $934k | Jul 27, 2026 |
| BIERMAN JAMES LDirector | Sell | 5.0k | $244.96 | $1.22M | Jul 27, 2026 |
| ARBOUR PAOLA MChief Technology Officer | Sell | 10.9k | $243.90 | $2.65M | Jul 27, 2026 |
| KERREY JOSEPH ROBERTDirector | Sell | 5.6k | $173.12 | $984k | May 28, 2026 |
| WEST NADJA Y.Director | Sell | 3.0k | $177.35 | $532k | May 27, 2026 |
| FITZGERALD MEGHANDirector | Other | 1.3k | — | — | May 22, 2026 |
| LYNCH CHRISTOPHER SDirector | Other | 1.3k | — | — | May 22, 2026 |
| WEST NADJA Y.Director | Other | 1.3k | — | — | May 22, 2026 |
| BLUNT ROYDirector | Other | 1.3k | — | — | May 22, 2026 |
| AGARWALA VINEETADirector | Other | 1.3k | — | — | May 22, 2026 |
| HANEY CECIL D.Director | Other | 1.3k | — | — | May 22, 2026 |
| ROMO TAMMYDirector | Other | 1.3k | — | — | May 22, 2026 |
Analyst Ratings
21 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 5 | 14 | 3 | 0 | 0 | Buy1.91 |
| 1 mo ago | 5 | 14 | 3 | 0 | 0 | Buy1.91 |
| 2 mo ago | 6 | 14 | 2 | 0 | 0 | Buy1.82 |